These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26504026)

  • 21. Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres.
    Hamad SA; Beale P; Yu JQ; Huq F
    J Biomed Sci; 2014 May; 21(1):41. PubMed ID: 24884683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate.
    Bodo J; Chovancova J; Hunakova L; Sedlak J
    Neoplasma; 2005; 52(6):510-6. PubMed ID: 16284698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models.
    Nessa MU; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2012 Nov; 32(11):4843-50. PubMed ID: 23155250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers.
    Sarwar S; Alamro AA; Alghamdi AA; Naeem K; Ullah S; Arif M; Yu JQ; Huq F
    Drug Des Devel Ther; 2021; 15():2211-2227. PubMed ID: 34079223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on two new mixed ligand platinum compounds with a trans-geometry.
    Al-Shuneigat J; Yu JQ; Beale P; Fisher K; Huq F
    Med Chem; 2010 Sep; 6(5):321-8. PubMed ID: 20977416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl.
    Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M
    Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.
    Yunos NM; Beale P; Yu JQ; Huq F
    Anticancer Res; 2011 Dec; 31(12):4283-9. PubMed ID: 22199293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4.
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the in vitro activity of platinum drugs when administered in two aliquots.
    Al-Eisawi Z; Beale P; Chan C; Yu JQ; Proschogo N; Molloy M; Huq F
    BMC Cancer; 2016 Aug; 16(1):688. PubMed ID: 27566066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.
    Althurwi SI; Yu JQ; Beale P; Huq F
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
    Horváth V; Blanárová O; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Fedorocko P; Kozubík A
    Gynecol Oncol; 2006 Jul; 102(1):32-40. PubMed ID: 16364413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
    Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-proliferative and pro-apoptotic effects from sequenced combinations of andrographolide and cisplatin on ovarian cancer cell lines.
    Yunos NM; Mutalip SS; Jauri MH; Yu JQ; Huq F
    Anticancer Res; 2013 Oct; 33(10):4365-71. PubMed ID: 24123004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants and platinum drugs.
    Engelmann BJ; Ryan JJ; Farrell NP
    Anticancer Res; 2014 Jan; 34(1):509-16. PubMed ID: 24403509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T; Masuda H; Naito M; Tamai H
    Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.